These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 5396491)

  • 1. Preliminary microbiological and pharmacological evaluation of a semisynthetic kasugamycin, BL-A 2.
    Misiek M; Chisholm DR; Leitner F; Price KE
    Antimicrob Agents Chemother (Bethesda); 1969; 9():225-32. PubMed ID: 5396491
    [No Abstract]   [Full Text] [Related]  

  • 2. Microbiological and pharmacological evaluation of BL-C 43, a new semisynthetic derivative of coumermycin A1.
    Price KE; Chisholm DR; Leitner F; Misiek M
    Antimicrob Agents Chemother (Bethesda); 1969; 9():209-18. PubMed ID: 5396489
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chemotherapeutic activity of acetoxymethyl derivatives of di-N-oxides of quinoxaline in acute bacterial infections].
    Padeĭskaia EN; Pershin GN; Belozerova KA
    Farmakol Toksikol; 1966; 29(6):702-9. PubMed ID: 4876657
    [No Abstract]   [Full Text] [Related]  

  • 4. [Choice of antibiotics in infections of the urinary tract].
    Yourassowsky E
    Acta Urol Belg; 1971; 39(4):533-7. PubMed ID: 4950454
    [No Abstract]   [Full Text] [Related]  

  • 5. [Chemotherapeutic action of quinozaline derivatives and N-oxides of quinoxaline in acute bacterial infections].
    Padeĭskaia EN; Elina AS; Pershin GN; Tsyrul'nikova LG; Belozerova KA
    Farmakol Toksikol; 1967; 30(5):617-26. PubMed ID: 4877416
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of the antibiotic sensitivity of bacteria by prospective surveys and possibilities of orienting therapy of infections].
    Teodorovici G; Zvorişteanu V; Ivan A; Groll M; Năstase A
    Rev Med Chir Soc Med Nat Iasi; 1970; 74(3):669-72. PubMed ID: 5474403
    [No Abstract]   [Full Text] [Related]  

  • 7. [The choice of an antibiotic in internal medicine: clinical and pharmacological criteria].
    Visco G
    Policlinico Prat; 1970 Jun; 77(22):709-23. PubMed ID: 5508590
    [No Abstract]   [Full Text] [Related]  

  • 8. Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii infections: characteristics and outcome in a series of 28 patients.
    Falagas ME; Rafailidis PI; Matthaiou DK; Virtzili S; Nikita D; Michalopoulos A
    Int J Antimicrob Agents; 2008 Nov; 32(5):450-4. PubMed ID: 18768302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bacteriological studies on a new antibiotic, Kasugamycin].
    Nakazawa S; Kanamori M; Ikunaga Y; Yamakawa N; Yoshida H
    J Antibiot B; 1967 Apr; 20(2):90-3. PubMed ID: 4964188
    [No Abstract]   [Full Text] [Related]  

  • 10. [Miocamycin: microbiological features].
    Renzini G; Scazzocchio F; Selan L
    Ann Ist Super Sanita; 1987; 23(4):883-6. PubMed ID: 3502551
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of BL-P1654: a semisynthetic penicillin as a topical ocular therapy.
    Cagle GD; Schlech BA
    Cornea; 1984; 3(1):27-32. PubMed ID: 6100241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antibiotics policy in Spanish hospitals: the role of the infections consultant in its optimization].
    Gómez J
    Med Clin (Barc); 1997 Sep; 109(8):300-1. PubMed ID: 9379753
    [No Abstract]   [Full Text] [Related]  

  • 13. -amino-p-hydroxybenzylpenicillin (BRL 2333), a new broad-spectrum semisynthetic penicillin: in vivo evaluation.
    Acred P; Hunter PA; Mizen L; Rolinson GN
    Antimicrob Agents Chemother (Bethesda); 1970; 10():416-22. PubMed ID: 5000266
    [No Abstract]   [Full Text] [Related]  

  • 14. Preclinical assessment of the antibacterial activity of nebramycin factor 6.
    Preston DA; Wick WE
    Antimicrob Agents Chemother (Bethesda); 1970; 10():322-7. PubMed ID: 4939737
    [No Abstract]   [Full Text] [Related]  

  • 15. A new powerful antibacterial synergistic combination of trimethoprim and trimeprazine.
    Guha Thakurta A; Mandal SK; Ganguly K; Dastidar SG; Chakrabarty AN
    Acta Microbiol Immunol Hung; 2000; 47(1):21-8. PubMed ID: 10735187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial activity of the antiinflammatory agent diclofenac sodium.
    Annadurai S; Basu S; Ray S; Dastidar SG; Chakrabarty AN
    Indian J Exp Biol; 1998 Jan; 36(1):86-90. PubMed ID: 9536657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and in vitro microbiological evaluation of imidazo(4,5-b)pyridinylethoxypiperidones.
    Aridoss G; Balasubramanian S; Parthiban P; Kabilan S
    Eur J Med Chem; 2006 Feb; 41(2):268-75. PubMed ID: 16380194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug resistance in Salmonella; comparison of isolates from Vietnam and the Netherlands].
    Vo A; van Duijkeren E; Fluit A; Gaastra W
    Tijdschr Diergeneeskd; 2008 Feb; 133(4):144-5. PubMed ID: 18384010
    [No Abstract]   [Full Text] [Related]  

  • 19. The treatment of bacterial infections in the newborn infant.
    Dashefsky B; Klein JO
    Clin Perinatol; 1981 Oct; 8(3):559-77. PubMed ID: 7030577
    [No Abstract]   [Full Text] [Related]  

  • 20. [Bacteriological evaluation of lividomycin].
    Nakazawa S; Otsuki M; Kuroda H; Kusumoto T; Tomita R
    Jpn J Antibiot; 1972 Dec; 25(6):329-35. PubMed ID: 4579556
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.